Rs to adverse drug reactions reporting in community pharmacy MedChemExpress Madecassoside settings in Dhaka, BangladeshMohammad Nurul Amin,1 Tahir Mehmood Khan,2 Syed Masudur Rahman Dewan,1 Mohammad Safiqul Islam,1 Mizanur Rahman Moghal,1 Long Chiau Ming3,To cite: Amin MN, Khan TM, Dewan SMR, PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/21330118 et al. Crosssectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. BMJ Open 2016;6:e010912. doi:ten.1136bmjopen-2015010912 Prepublication history for this paper is accessible on the web. To view these files please stop by the journal on-line (http:dx.doi.org10.1136 bmjopen-2015-010912). Received 21 December 2015 Revised 29 March 2016 Accepted 29 AprilABSTRACT Objectives: To assess community pharmacists’pharmacy technicians’ knowledge and perceptions about adverse drug reactions (ADRs) and barriers towards the reporting of such reactions in Dhaka, Bangladesh. Strategy: A cross-sectional study was planned to strategy prospective respondents for the study. A selfadministered questionnaire was delivered to neighborhood pharmacistspharmacy technicians (N=292) practising in Dhaka, Bangladesh. Benefits: The general response towards the survey was 69.five (n=203). The majority of the sample was comprised of pharmacy technicians (152, 74.9 ) who possessed a diploma in pharmacy, followed by pharmacists (37, 18.2 ) and other people (12, five.9 ). All round, 72 (35.five ) with the respondents disclosed that they had experienced an ADR at their pharmacy, however more than half (105, 51.7 ) weren’t acquainted with the existence of an ADR reporting physique in Bangladesh. Exploring the barriers to the reporting of ADRs, it was revealed that the prime 4 barriers to ADR reporting have been `I do not understand how to report (Relative Value Index (RII)=0.998)’, `reporting types usually are not out there (0.996)’, `I am not motivated to report (0.997)’ and `Unavailability of expert environment to go over about ADR (RII=0.939)’. Furthermore to these, a majority (141, 69.46 ) weren’t confident regarding the classification of ADRs (RII=0.889) and had been afraid of legal liabilities associated with reporting ADRs (RII=0.806). In addition, a lack of know-how about pharmacotherapy along with the detection of ADRs was another important aspect hindering their reporting (RII=0.731). Conclusions: The Directorate of Drug Administration in Bangladesh must think about the results of this study to help it enhance and simplify ADR reporting in Bangladeshi neighborhood pharmacy settings.Strengths and limitations of this studyFindings in the present study will assist policymakers to understand the challenges to adverse drug reactions (ADRs) reporting in neighborhood pharmacy settings and hence to intervene to make the ADR reporting procedure a lot easier and more accessible to pharmacists and pharmacy technicians practising in Bangladesh. The Directorate of Drug Administration in Bangladesh can make the ADR reporting method much more effective by making the reporting forms easier to access. Moreover, offered that unavailability of an expert atmosphere to talk about about ADR was a significant barrier identified for the reporting of ADRs, the Bangladeshi Pharmacy Association and registration councils can play a proactive role in organising frequent continuous education and training events where pharmacists get the chance to talk about such experiences with other pharmacists. Among the list of possible limitations will be the compact number of pharmacists who participated in this study. Nonetheless, the complete sample was representative of Banglades.
Posted inUncategorized